BCM
MACK

BlueCrest Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

BlueCrest Capital Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-27,269
Closed -$114K – 1715
2018
Q3 		$114K Buy
27,269
+972
+4% +$4.06K ﹤0.01% 1357
2018
Q2 		$102K Buy
+26,297
New +$102K ﹤0.01% 1356
2017
Q3 		– Sell
-3,305
Closed -$32K – 1201
2017
Q2 		$32K Buy
+3,305
New +$32K ﹤0.01% 850